Cargando…

The association between residual neuromuscular blockade (RNMB) and critical respiratory events: a prospective cohort study

BACKGROUND: Inadequate neuromuscular recovery might impair pulmonary function among adult patients who undergo general anaesthesia and might thus contribute to critical respiratory events in the post-anaesthesia care unit (PACU). The pilot study aims to understand the baseline incidence of residual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alenezi, Faraj K, Alnababtah, Khalid, Alqahtani, Mohammed M, Olayan, Lafi, Alharbi, Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094541/ https://www.ncbi.nlm.nih.gov/pubmed/33941287 http://dx.doi.org/10.1186/s13741-021-00183-7

Ejemplares similares

Residual neuromuscular blockade and late neuromuscular blockade at the post-anesthetic recovery unit: prospective cohort study
por: Gonçalves, Pedro Marcos Silva e, et al.
Publicado: (2020)

Neuromuscular blockade management in the critically Ill patient
por: Renew, J. Ross, et al.
Publicado: (2020)

Quantitative Relationships between Pulmonary Function and Residual Neuromuscular Blockade
por: Fu, ShuYing, et al.
Publicado: (2018)

Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study
por: Domenech, Gonzalo, et al.
Publicado: (2019)

Predictive study of pharmacological reversal for residual neuromuscular blockade and postoperative pulmonary complications: a prospective, observational, cohort study
por: Aragón-Benedí, Cristian, et al.
Publicado: (2022)

Qualitative Neuromuscular Monitoring: How to Optimize the Use of a Peripheral Nerve Stimulator to Reduce the Risk of Residual Neuromuscular Blockade
por: Thilen, Stephan R., et al.
Publicado: (2016)

The Status of Respiratory Care Education in Saudi Arabia: A National Survey of Program Directors
por: Almeshari, Mohammed A, et al.
Publicado: (2022)

Management of Residual Neuromuscular Blockade Recovery: Age-Old Problem with a New Solution
por: Green, Michael S., et al.
Publicado: (2017)

Residual Neuromuscular Blockade and Postoperative Pulmonary Complications: What Does the Recent Evidence Demonstrate?
por: Cammu, Guy
Publicado: (2020)

Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade With E-Learning: Protocol for the Multicenter Interrupted Time Series INVERT Study
por: Thomsen, Jakob Louis Demant, et al.
Publicado: (2017)

Neuromuscular blockade in the elderly patient
por: Lee, Luis A, et al.
Publicado: (2016)

Intraoperative Monitoring of Neuromuscular Blockade
por: Motamed, Cyrus
Publicado: (2023)

Incidence of postoperative residual neuromuscular blockade − A multicenter, observational study in Portugal (INSPIRE 2)
por: Esteves, Simão, et al.
Publicado: (2023)

Characteristics and Outcomes of Liver Transplantation Recipients after Tranexamic Acid Treatment and Platelet Transfusion: A Retrospective Single-Centre Experience
por: Alsabani, Mohmad H., et al.
Publicado: (2023)

Prolonged neuromuscular blockade by non-depolarizing neuromuscular blocking agents
por: Higashi, Michiko, et al.
Publicado: (2019)

Effect of sevoflurane anesthesia on neuromuscular blockade produced by rocuronium infusion in dogs
por: SAKATA, Hisashi, et al.
Publicado: (2019)

Improving neuromuscular monitoring and reducing residual neuromuscular blockade via e‐learning: A multicentre interrupted time‐series study (INVERT study)
por: Thomsen, Jakob Louis Demant, et al.
Publicado: (2022)

Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome
por: Ledowski, Thomas, et al.
Publicado: (2013)

The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review
por: Liu, Guangyu, et al.
Publicado: (2017)

Novel drug development for neuromuscular blockade
por: Prabhakar, Amit, et al.
Publicado: (2016)

The immunological response among COVID-19 patients with acute respiratory distress syndrome
por: Almutairi, Abdulaziz S., et al.
Publicado: (2021)

Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome
por: Rudolph, Michelle W., et al.
Publicado: (2022)

Comparison of onset of neuromuscular blockade with electromyographic and acceleromyographic monitoring: a prospective clinical trial
por: Chaves-Cardona, Harold E., et al.
Publicado: (2023)

Effect of ulinastatin on the rocuronium-induced neuromuscular blockade
por: Kim, Min Soo, et al.
Publicado: (2012)

Observational study on patterns of neuromuscular blockade reversal
por: Dubovoy, Timur, et al.
Publicado: (2016)

Improved oxygenation after discontinuing neuromuscular blockade
por: Willson, D. F., et al.
Publicado: (1997)

Neuromuscular blockade management in patients with COVID-19
por: Chaves-Cardona, Harold, et al.
Publicado: (2021)

Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021)

Effects of neuromuscular presynaptic muscarinic M(1) receptor blockade on rocuronium‐induced neuromuscular blockade in immobilized tibialis anterior muscles
por: Kim, Yong Beom, et al.
Publicado: (2018)

At therapeutic concentration bupivacaine causes neuromuscular blockade and enhances rocuronium-induced blockade
por: Lee, Ji Hyeon, et al.
Publicado: (2012)

A surgeon’s assessment of inadequate neuromuscular antagonism in a case of prolonged neuromuscular blockade
por: Lamberg, James J, et al.
Publicado: (2013)

Respiratory muscle activity after spontaneous, neostigmine- or sugammadex-enhanced recovery of neuromuscular blockade: a double blind prospective randomized controlled trial
por: Schepens, Tom, et al.
Publicado: (2019)

A retrospective study of sugammadex for reversal of neuromuscular blockade induced by rocuronium in critically ill patients in the ICU
por: Bologheanu, Răzvan, et al.
Publicado: (2022)

Neuromuscular blockade administration is associated with altered energy expenditure in critically ill intubated patients with COVID-19
por: Karayiannis, D., et al.
Publicado: (2022)

A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome
por: Macario, Alex, et al.
Publicado: (2006)

Design and rationale of the CHILL phase II trial of hypothermia and neuromuscular blockade for acute respiratory distress syndrome
por: Shanholtz, Carl B., et al.
Publicado: (2023)

Abdominal compartment syndrome successfully treated with neuromuscular blockade
por: Chiles, Kris T, et al.
Publicado: (2011)

Neuromuscular Blockade Correlates with Hormones and Body Composition in Acromegaly
por: Zhang, Yu, et al.
Publicado: (2020)

Neuromuscular Blockade in the Pre- and COVID-19 ARDS Patients
por: Tsolaki, Vasiliki, et al.
Publicado: (2022)

Neuromuscular Blockade Monitoring: Having It but Knowing When Not to Trust It
por: Salvador, Sara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_utbefveoms275vhefcd3j4rne5